| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group F | 0.535 | 0.731 | 0.46 |
|
disease | 0.510 | strong | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
disease | 0.510 | strong | 1.000 | 1 | 0 | 2016 | 2017 | ||||||||
|
myosin heavy chain 11 | 0.528 | 0.731 | 0.77 |
|
disease | 0.500 | None | 0.960 | 99 | 0 | 1995 | 2020 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
disease | 0.500 | None | 0.987 | 73 | 2 | 1992 | 2020 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.500 | None | 0.972 | 72 | 1 | 2000 | 2020 | ||||||||
|
core-binding factor subunit beta | 0.601 | 0.538 | 0.96 |
|
disease | 0.500 | None | 0.966 | 56 | 0 | 1993 | 2020 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
disease | 0.500 | None | 0.980 | 47 | 0 | 1995 | 2019 | ||||||||
|
MLLT10 histone lysine methyltransferase DOT1L cofactor | 0.551 | 0.462 | 1.00 |
|
disease | 0.500 | None | 0.958 | 24 | 0 | 1995 | 2019 | ||||||||
|
nucleoporin 214 | 0.638 | 0.385 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 16 | 0 | 1999 | 2019 | ||||||||
|
growth factor independent 1 transcriptional repressor | 0.546 | 0.769 | 0.25 |
|
disease | 0.500 | None | 1.000 | 15 | 0 | 2007 | 2020 | ||||||||
|
myeloid leukemia factor 1 | 0.666 | 0.385 | 4.4E-09 |
|
disease | 0.500 | None | 1.000 | 14 | 0 | 1996 | 2019 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.500 | None | 1.000 | 13 | 0 | 2000 | 2020 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.500 | None | 1.000 | 12 | 2 | 2003 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.833 | 9 | 2 | 1987 | 2016 | ||||||||
|
phosphatidylinositol binding clathrin assembly protein | 0.592 | 0.538 | 1.00 |
|
disease | 0.490 | None | 1.000 | 7 | 0 | 2000 | 2012 | ||||||||
|
inositol polyphosphate-4-phosphatase type II B | 0.573 | 0.577 | 0.55 |
|
disease | 0.480 | None | 1.000 | 8 | 0 | 2015 | 2019 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
disease | 0.470 | None | 1.000 | 7 | 0 | 2011 | 2019 | ||||||||
|
catenin alpha 1 | 0.584 | 0.538 | 0.97 |
|
disease | 0.450 | None | 1.000 | 5 | 0 | 2007 | 2017 | ||||||||
|
septin 9 | 0.548 | 0.769 | 1.00 |
|
disease | 0.440 | None | 1.000 | 4 | 0 | 1999 | 2017 | ||||||||
|
Janus kinase 1 | 0.474 | 0.769 | 1.00 |
|
disease | 0.430 | None | 1.000 | 3 | 0 | 2008 | 2018 | ||||||||
|
neurotrophic receptor tyrosine kinase 3 | 0.522 | 0.692 | 1.00 |
|
disease | 0.430 | None | 0.800 | 3 | 0 | 1999 | 2018 | ||||||||
|
cysteine rich hydrophobic domain 2 | 0.769 | 0.231 | 0.54 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
charged multivesicular body protein 5 | 0.751 | 0.192 | 6.7E-03 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
disease | 0.400 | None | 0.986 | 284 | 4 | 1993 | 2020 |